Ku ya 15 Ukuboza 2025, Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi mu Bushinwa cyemeje ku mugaragaro itangizwa ry’isoko ry’umuti mushya urwanya kanseri witwa zurletrectinib (ICP-723). Iri terambere rikomeye rizana icyizere cy’ubuvuzi kidasanzwe ku barwayi bo ku isi yose bafite ibibyimba bikomeye bifite imiterere ya NTRK fusion.
**Ubuvuzi bw'impinduramatwara bwa "Tumor-Agnostic": Impinduka mu bya siyansi ya Zurletrectinib**
Zurletrectinib ni umuti wa mbere mu Bushinwa wo mu bwoko bushya wa TRK inhibitor, wagenewe by’umwihariko abarwayi bafite ibibyimba bikomeye cyangwa bya metastatic bifite Neurotrophic Tyrosine Receptor Kinase (NTRK) fusion genes. Uyu muti wa "tumor-agnostic" urwanya kanseri ugaragaza impinduka mu rwego rwo kuvura kanseri—kuva ku rwego gakondo rw’aho umuntu akomoka no kuvura kugeza ku buvuzi bugamije ubuvuzi bushingiye ku mpinduka mu ngirabuzimafatizo.
**Ibimenyetso by'ingenzi:**
* Abarwayi basuzumwe binyuze mu isuzuma ryemewe ryuzuye ko bafite gene ya NTRK fusion (hatarimo impinduka zizwi zo kurwanya indwara).
* Abarwayi bakuru n'ingimbi (abafite imyaka 12 no hejuru) bafite ibibyimba bikomeye badafite ubundi buryo bwo kuvura buhagije cyangwa ubuvuzi bwabo bwa mbere bwarananiranye.
**Akarusho k'ingenzi:**
Igihe cyose gene ya NTRK fusion igaragaye binyuze mu isuzuma ry’uturemangingo, abarwayi bashobora kungukirwa cyane n’ubuvuzi bwa zurletrectinib, hatitawe ku kuba ikibyimba cyaraturutse mu bihaha, tiroyide, ibere, amara, cyangwa ahandi hantu.
**Amakuru y'ubuvuzi adasanzwe: Gusobanura bundi bushya ibyo umuntu yiteze ku buvuzi**
Igeragezwa rya zurletrectinib ryakorewe mu Bushinwa ryagaragaje ko rifite umusaruro utangaje, ritanga icyizere gikomeye cyo kubaho ku barwayi bafite ibibyimba bikomeye:
* **Igipimo rusange cy'ubutabazi (ORR): 89.1%** — Hafi 90% by'abarwayi bahuye n'ikibazo cyo kugabanuka cyane kw'ikibyimba.
* **Igipimo cyo Kurwanya Indwara (DCR): 96.4%** — Iterambere ry'indwara ryagenzuwe neza mu barwayi hafi ya bose.
* **Igipimo cy'amezi 24 cyo kubaho nta ndwara (PFS): 77.4%** — Kugenzura igihe kirekire ikwirakwira ry'indwara.
* **Igipimo cy'amezi 24 cyo kubaho (OS): 90.8%** — Igihe cyo kubaho cy'umurwayi cyarakomeje cyane.
**Ishami Mpuzamahanga ry'Ibitaro bya Oncology byo mu Karere k'Amajyepfo muri Beijing: Inzira yawe yo kuvura kanseri mu buryo bugezweho**
Ishami Mpuzamahanga ry’Ibitaro bya Oncology byo mu Karere k’Amajyepfo rya Beijing ryiyemeje guha abarwayi bo ku isi uburyo bwo kuvura kanseri bugezweho. Itsinda ryacu mpuzamahanga ry’abaganga ryiyemeje gutanga ubufasha bw’ubuvuzi busesuye kandi bwihariye kuri buri murwayi mpuzamahanga.
Serivisi zacu zihariye zirimo:
1. Inama mpuzamahanga ku kuvura abarwayi no kubasuzuma.
2. Gutegura no gusobanura igeragezwa rya NTRK fusion gene.
3. Ubujyanama bw'impuguke mu nzego zitandukanye no gutegura uburyo burambuye bwo kuvura.
4. Ubufasha mu guhindura inyandiko mu buryo bw'ubuvuzi mu ndimi nyinshi no mu bijyanye no guhuza umuco.
**Hagarara Ishami Mpuzamahanga ry'Ibitaro bya Oncology bya Beijing mu Karere k'Amajyepfo**
Dusobanukiwe ingorane n'ibibazo abarwayi mpuzamahanga bahura na byo iyo bagiye kwivuza mu mahanga. Kubwibyo, twashyizeho uburyo bworoshye kandi butandukanye bwo gutumanaho kugira ngo tubashe kubona amakuru yemewe y’ubuvuzi no gutangiza inzira yo kuvura.
**Uburyo bwo Guhuza Abantu Bwifuzwa:**
* Umurongo Mpuzamahanga w'Umuganga wita ku Barwayi: 400-880-3716
**Imiyoboro itandukanye yo Guhuza:**
* Ubujyanama kuri WeChat: Ongeraho indangamuntu “17801183037″ kugira ngo ubone inama ishingiye ku butumwa n'ibisubizo byihuse.
* Ubujyanama kuri email:
* General Inquiry: 100085_010@163.com
* International Medical Exclusive: myimmnet@163.com
**Inzira Mpuzamahanga y'Abarwayi:**
1. Vugana n'Umuhuzabikorwa wacu Mpuzamahanga w'Abarwayi ukoresheje uburyo ubwo aribwo bwose bwavuzwe haruguru.
2. Tanga inyandiko z'ubuvuzi kugira ngo zikoreshwe mu isuzuma ry'ibanze (harimo raporo z'indwara, ibisubizo by'ibizamini bya gene, nibindi).
3. Teganya ko uzajya kubonana n'impuguke mpuzamahanga mu bijyanye n'indwara za kanseri mu buryo bwa videwo.
4. Niba bikenewe kuvurwa mu Bushinwa, tuzagufasha mu gutunganya viza yo kwa muganga, gutegura icumbi, n'ibindi bikoresho.
5. Ishimire serivisi z'ubuvuzi zitangwa rimwe gusa ugeze i Beijing, kuva ku ifatwa ry'indege kugeza ku rugendo rwose rwo kuvurwa.
**Icyibutswa cy'ingenzi: Gupima imiterere y'uturemangingo mbere yo kuvurwa ni ingenzi**
Nk'umuti wibandwaho, akamaro ka zurletrectinib gashingiye cyane ku isuzuma ry’imiterere y’umubiri. Turasaba ko abarwayi bose batekereza ubu buvuzi babanza gupimwa imiterere y’umubiri ya NTRK. Ishami ry’Ibitaro Mpuzamahanga bya Oncology bya Beijing mu Karere k’Amajyepfo rishobora kugutegurira serivisi zo gupima zizwi ku rwego mpuzamahanga cyangwa gutanga ibisobanuro byemewe by’ibyavuye mu isuzuma ryawe.
**Gutegereza Imbere: Igihe Gishya cyo Kuvura Kanseri Yihariye**
Kwemezwa kwa zurletrectinib si ugutangiza gusa umuti mushya; ni igihamya gikomeye cy'ubushobozi bw'Ubushinwa mu kuvura kanseri neza. Ishami Mpuzamahanga ry'Ibitaro Mpuzamahanga bya Oncology bya Beijing mu Karere k'Amajyepfo rizakomeza gukurikirana iterambere ry'isi mu kuvura kanseri, rihuze ubuvuzi bwiza buturuka mu bihugu byo mu gihugu no mu mahanga, kandi ritange serivisi zo gusuzuma kanseri zishingiye ku barwayi mpuzamahanga ku rwego rw'isi.
**Hagarara nonaha ubaze niba wowe cyangwa uwo ukunda ari umukandida w'ubu buvuzi bushya!**
Telefoni Mpuzamahanga y'Ishami ry'Ishami ry'Abaganga Mpuzamahanga mu Bitaro bya Oncology bya Beijing mu Karere k'Amajyepfo: 400-880-3716
Indangamuntu ya WeChat: 17801183037
Email: 100085_010@163.com; myimmnet@163.com
**Icyitonderwa:** Amakuru y’ubuvuzi ari muri iyi nkuru ashingiye ku makuru y’igerageza ry’ubuvuzi aboneka ku mugaragaro. Gahunda zihariye zo kuvura zigomba gutegurwa n’abaganga b’inzobere hashingiwe ku miterere y’umurwayi ku giti cye. Ni byiza ko abarwayi bose bagisha inama abaganga b’inzobere mbere yo gutekereza ku buvuzi ubwo aribwo bwose.
Igihe cyo kohereza: Ukuboza 31-2025